Adaptive Designs in Clinical Drug Development
26 Mar 2012 - 27 Mar 2012 - London, UK
‘Buying in’ to adaptive design trials: strategies and methods for implementing successful adaptive design studies Monday 26th & Tuesday 27th March 2012, Grange Holborn, London
SMi are proud to present the 6th Annual Adaptive Designs in Clinical Drug Development conference, following on from SMi’s previous highly successful Adaptive Designs events and offers the opportunity to keep up-to-date with the latest challenges and solutions essential for successful and cost-effective adaptive clinical trials.
In recent years, the use of adaptive design in clinical trials has been considered an efficient and optimal way of designing clinical trials. Adaptive design has gradually evolved from a novel idea into a standard norm in the pharmaceutical industry. This new clinical paradigm could change the way traditional clinical trials, with their restrictive guidance, are run today.
With more flexibility, faster development timelines and significant monetary savings, an adaptive design trial is the way forward.
The conference will address adaptive clinical trials for rare disease medicine development. The agenda will not only tackle issues surrounding effective management of your adaptive design in clinical trials but the increasing use of Bayesian modelling and using adaptive designs in early clinical trials. As adaptive designs are recently gradually evolving from a novel idea into a standard norm in the pharmaceuticals industry, industry leaders are asking themselves whether to adapt or not to adapt.
Key Reasons to attend Adaptive Designs in Clinical Drug Development;
• Learn how to maximise the benefits of an adaptive design through effective management
• Develop your knowledge of the adaptive designs. From start to end, it is important to know everything about adaptive clinical trials to gain maximum advantage.
• Understand the challenges of the high-density biomarker adaptive trial.
• Discover what the future holds in this rapidly evolving market and the impact of new regulation and technology.
• Improve your clinical trials in early phases to reduce costs and time.
• Evolve your understanding of current technologies to protect trial integrity, reduce operational bias and build regulatory confidence.
• Network with key industry professionals
Visit the website to register: http://www.smi-online.co.uk/2012adaptivedesigns9.asp
Alternatively or contact Shilan Chandi on: +44 (0)20 7827 6738 e-mail: firstname.lastname@example.org